Position in NTLA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$29,718,167
+$12,350,847 QoQ
Shares Held
2,318,110
+20.0% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 6%
None 4%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. NTLA ranks #40 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,718,167 | 2,318,110 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $17,367,320 | 1,931,849 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $30,348,465 | 1,757,294 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,505,977 | 1,866,309 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,993,658 | 1,968,166 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $23,042,630 | 1,976,212 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,740,985 | 1,447,250 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $29,643,673 | 1,324,561 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $33,718,894 | 1,225,696 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $35,698,574 | 1,170,829 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $35,100,759 | 1,110,081 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $41,850,106 | 1,026,241 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $30,579,734 | 820,492 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $32,101,448 | 920,076 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $50,929,641 | 910,108 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $47,562,158 | 918,898 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $68,727,434 | 945,747 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $125,028,158 | 1,057,410 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $153,032,685 | 1,140,758 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $184,629,373 | 1,140,321 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $79,352,372 | 988,753 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $53,555,331 | 984,473 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $20,204,680 | 1,016,332 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $22,460,416 | 1,068,526 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $12,529,683 | 1,024,504 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||